SCHEMBL4466182

SCHEMBL4466182

NCC(=O)Nc1ccncn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.47
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47
CHRNA3 P32297 1/20 0.47
CHRNA4 P43681 1/20 0.47
EPHX2 P34913 1/20 0.46
GAA P10253 1/20 0.44
ATR Q13535 1/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
JAK2 O60674 2/20 0.42
TYK2 P29597 2/20 0.42
MKNK1 Q9BUB5 1/20 0.41
NLRP3 Q96P20 3/20 0.41
FAAH O00519 1/20 0.40
NAMPT P43490 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
JAK1 P23458 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19308440 0.84 TDP1 (0.55) P2RX7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL14920768 0.84 CHRNB2 (0.51) P2RX7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL2685376 0.82 CHRNB2 (0.47) P2RX7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL1433052 0.82 P2RX7 (0.47) P2RX7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL6361625 0.82 SMN1; SMN2 (0.47) P2RX7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL5262945 0.79 CHRNB2 (0.50) P2RX7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL31579540 0.79 CHRNB2 (0.50) P2RX7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL19177369 0.79 RAB9A (0.49) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL20924813 0.79 CHRNB2 (0.44) P2RX7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL19116526 0.78 SMN1; SMN2 (0.57) P2RX7CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2008124085-A2 METHODS OF USING COMBINATIONS OF MEK AND JAK-2 INHIBITORS EXELIXIS, INC. (US) 2008-10-16 WO claimed